Thrasos Therapeutics Inks $35M
Thrasos Therapeutics has raised $35 million for its treatment of acute kidney injury. SR One led the round, with additional funds coming from the GSK Canada Life Sciences Innovation Fund, SW Co., Advanced Technology Ventures, Fonds de solidarité FTQ, Lumira Capital, MP Healthcare Venture Management and Pappas Ventures.
25 October 2012•4 mins read
